A

Apollo Healthcare Corp
TSX:AHC

Watchlist Manager
Apollo Healthcare Corp
TSX:AHC
Watchlist
Price: 4.5 CAD 0.22% Market Closed
Market Cap: CA$327.3m

Apollo Healthcare Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Apollo Healthcare Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
A
Apollo Healthcare Corp
TSX:AHC
Research & Development
-CA$1m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Flora Growth Corp
NASDAQ:FLGC
Research & Development
-$418k
CAGR 3-Years
-48%
CAGR 5-Years
-84%
CAGR 10-Years
N/A
Genix Pharmaceuticals Corp
XTSX:GENX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitality Products Inc
XTSX:VPI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jamieson Wellness Inc
TSX:JWEL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Leef Brands Inc
CNSX:LEEF
Research & Development
-$23k
CAGR 3-Years
72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Apollo Healthcare Corp
Glance View

Market Cap
327.3m CAD
Industry
Consumer products

Apollo Healthcare Corp. engages in manufacturing and developing private label personal care products and retailer-branded products for North American retailers. The company is headquartered in Toronto, Ontario and currently employs 500 full-time employees. The company went IPO on 2015-09-08. The firm is engaged in developing and manufacturing retailer branded and private label products for North American retailers. The firm operates through private label consumer staples business segment. The Company’s products are sold in stores across North America and serves North American grocery, drug, and mass merchandise retailers, as well as wholesale clubs. Along with private label, the Company also manufactures products on a contract basis for its clients.

AHC Intrinsic Value
Not Available
A

See Also

What is Apollo Healthcare Corp's Research & Development?
Research & Development
-1m CAD

Based on the financial report for Dec 31, 2020, Apollo Healthcare Corp's Research & Development amounts to -1m CAD.

What is Apollo Healthcare Corp's Research & Development growth rate?
Research & Development CAGR 3Y
22%

Over the last year, the Research & Development growth was 9%. The average annual Research & Development growth rates for Apollo Healthcare Corp have been 22% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett